Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Randomized Experiments

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

One-Way ANOVA: Unequal Sample Sizes

One-Way ANOVA: Unequal Sample Sizes

One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:

One-Way ANOVA: Equal Sample Sizes

One-Way ANOVA: Equal Sample Sizes

One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Durability and Seasonal Variation in the Effectiveness of Nirsevimab over Three Seasons in Connecticut.

medRxiv : the preprint server for health sciences·2026

Same author

Design of field trials for the evaluation of transmissible vaccines in animal populations.

PLoS computational biology·2025

Same author

Quasi-experimental methods for pharmacoepidemiology: difference-in-differences and synthetic control methods with case studies for vaccine evaluation.

American journal of epidemiology·2024

Same author

The required size of cluster randomized trials of nonpharmaceutical interventions in epidemic settings.

Statistics in medicine·2022

Same author

Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.

Clinical trials (London, England)·2021

Same author

Joint Estimation of Generation Time and Incubation Period for Coronavirus Disease 2019.

The Journal of infectious diseases·2021

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

A generalized difference-in-differences estimator for stepped-wedge cluster-randomized trials.

Lee Kennedy-Shaffer¹

¹Department of Biostatistics, Yale School of Public Health, New Haven, CT 06511, United States.

|June 16, 2026

Summary

This summary is machine-generated.

This study introduces a new non-parametric method for analyzing staggered treatment adoption in stepped-wedge trials (SWTs). The approach offers interpretable and unbiased estimates, balancing bias, variance, and generalizability.

Keywords:

causal inference cluster-randomized trial natural experiment panel data quasi-experimental design

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: Jun 17, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

Epidemiology
Biostatistics
Health Services Research

Background:

Staggered treatment adoption is common in policy evaluations using stepped-wedge trials (SWTs) and quasi-experiments.
Accurate estimation of policy impact requires careful handling of treatment effect heterogeneity.

Purpose of the Study:

To propose a novel non-parametric method for interpretable and unbiased effect estimation in SWTs.
To address challenges in estimating treatment effects with staggered adoption and potential heterogeneity.

Main Methods:

Developed a non-parametric estimator using weighted averages of two-by-two difference-in-differences comparisons.
The method allows targeting specific estimands under various treatment effect heterogeneity assumptions.
Provided an algorithm and R code for implementation and comparison with existing methods.

Main Results:

Demonstrated the method's application in a randomized SWT evaluating tuberculosis diagnostic tools.
Compared results with previous methods in both real-world and simulated settings.
The proposed method offers flexibility in targeting effects and addresses the bias-variance-generalizability tradeoff.

Conclusions:

The novel non-parametric approach provides a flexible and interpretable solution for analyzing staggered treatment adoption in SWTs.
It enhances the ability to obtain unbiased effect estimates while managing precision and generalizability.
This method facilitates robust policy impact and implementation evaluations.